Skip to main content
Quest Diagnostics

Prevalence and Relative Distributions of Clonazepam and 7-aminoclonazepam in a Large-Scale Oral Fluid Study

SOFT 2025

Society for Forensic Toxicologists

Portland, OR, Oct 26-31, 2025

Poster presentation: Prevalence and Relative Distributions of Clonazepam and 7-aminoclonazepam in a Large-Scale Oral Fluid Study

Authors: Evans T, Dui W, Smith MP, Bartock SH

Medical Specialty: Prescription Drug Monitoring, Toxicology

Related content

Test FAQ
Drug Toxicology Monitoring Oral Fluid Testing
Audio Podcast
Why and When to Use Oral Fluid Testing
On-Demand Webinar
The Growing Crisis of Novel Psychoactive Substances
Conference Presentation
The Emergence of the Designer Stimulants Fluorexetamine and 2-fluoro-2oxo-PCE in Clinical Urine Specimens
Test FAQ
Drug Testing General Toxicology Blood or Serum
Audio Podcast
Drug Testing for Stimulants

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.